Early Chest Tube Removal for Lung Surgery
(PROTECTR Trial)
Trial Summary
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Early Chest Tube Removal for Lung Surgery?
Is early chest tube removal generally safe for humans?
How is the treatment of early chest tube removal for lung surgery different from other treatments?
What is the purpose of this trial?
This study is a single centre, prospective clinical trial evaluating the safety and feasibility of implementing a same day chest tube removal protocol in patients undergoing Video Assisted Thoracic Surgery (VATS) anatomical pulmonary surgery.
Research Team
Rahul Nayak, MD MSc
Principal Investigator
Western University
Eligibility Criteria
This trial is for patients who have undergone a minimally invasive lung surgery called VATS. It's testing if it's safe and possible to remove the chest tube on the same day of surgery, which could enhance recovery.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Video Assisted Thoracic Surgery (VATS) with early chest tube removal at 3 hours post-operation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of complications and quality of life
Treatment Details
Interventions
- Early Chest Tube Removal
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lawson Health Research Institute
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre OR Lawson Research Institute of St. Joseph's
Lead Sponsor
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Lead Sponsor